Arterial elastic fiber structure. Function and potential roles in acute aortic dissection

Journal of Cardiovascular Surgery

Volumn 51, Issue 5, 2010, Pages 647-656

  Pratt, B ^a   Curci, J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aneurysm; Aortic dissection; Aortic rupture

Indexed keywords

GELATINASE B; SCAFFOLD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE DISEASE; AORTA ANEURYSM; AORTA DISSECTION; AORTA RUPTURE; AORTA WALL; ELASTIC FIBER; HUMAN; MARFAN SYNDROME; REVIEW; UPREGULATION; VASODILATATION;

ACUTE DISEASE; ANEURYSM, DISSECTING; AORTIC ANEURYSM; AORTIC RUPTURE; ELASTIC TISSUE; HEMODYNAMICS; HUMANS; MATRIX METALLOPROTEINASES; TRANSFORMING GROWTH FACTOR BETA;

EID: 78650736087     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Olsson C, Thelin S, Stahle E, Ekbom A, Granath F. Thoracic aortic aneurysm and dissection: increasing prevalence and improved outcomes reported in a Nationwide Population-Based Study of More Than 14 000 Cases From 1987 to 2002. Circulation 2006;114:2611-8.
2. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA 2000;283:897-903.
3. Asfoura JY, Vidt DG. Acute aortic dissection. Chest 1991;99:724-9.
4. Sage H, Gray WR. Studies on the evolution of elastin-I. Phylogenetic distribution. Comp Biochem Physiol B 1979;64:313-27.
5. Kielty CM, Wess TJ, Haston L, Ashworth JL, Sherratt MJ, Shuttleworth CA. Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix. J Muscle Res Cell Motil 2002;23:581-96.
6. Mecham RP. Elastin synthesis and fiber assembly. Annals of the New York Academy of Sciences 1991;624:137-46.
7. Kozel BA, Wachi H, Davis EC, Mecham RP. Domains in tropoelastin that mediate elastin deposition in vitro and in vivo. J Biol Chem 2003;278:18491-8.
8. Kagan HM, Li W. Lysyl oxidase: properties, specificity, and biological roles inside and outside of the cell. J Cell Biochem 2003;88:660-72.
9. Bendeck MP, Keeley FW, Langille BL. Perinatal accumulation of arterial wall constituents: relation to hemodynamic changes at birth. Am J Physiol 1994;267:H2268-79.
10. Bendeck MP, Langille BL. Rapid accumulation of elastin and collagen in the aortas of sheep in the immediate perinatal period. Circ Res 1991;69:1165-9.
11. Shapiro SD, Endicott SK, Province MA, Pierce JA, Campbell EJ. Marked longevity of human lung parenchymal elastic fibers deduced from prevalence of D-aspartate and nuclear weaponsrelated radiocarbon. J Clin Invest 1991;87:1828-34.
12. Dubick MA, Rucker RB, Cross CE, Last JA. Elastin metabolism in rodent lung. Biochimica et Biophysica Acta 1981;672:303-6.
13. Curci JA, Thompson RW. Adaptive cellular immunity in aortic aneurysms: Cause, consequence, or context? J Clin Invest 2004;114:168-71.
14. O'Rourke MF. Arterial aging: pathophysiological principles. Vase Med 2007;12:329-41.
15. Homme JL, Aubry MC, Edwards WD, Bagniewski SM, Shane Pankratz V, Krai CA et al. Surgical pathology of the ascending aorta: a clinicopathologic study of 513 cases. Am J Surg Pathol 2006;30:1159-68.
16. Luk A, Leong S, Soor G, Borger M, Butany J. Histological analysis of aortic dissections following previous cardiovascular surgery. Cardiovasc Pathol 2008;17:199-205.
17. Matt P, Huso DL, Habashi J, Holm T, Doyle J, Schoenhoff F et al. Murine model of surgically induced acute aortic dissection type A. J Thorac Cardiovasc Surg 2010;139:1041-7.
18. Chapman SL, Sicot FX, Davis EC, Huang J, Sasaki T, Chu ML et al. Fibulin-2 and fibulin-5 cooperatively function to form the internal elastic lamina and protect from vascular injury. Arterioscler Thromb Vase Biol 2009;30:68-74.
19. Midwood KS, Schwarzbauer JE. Elastic fibers: building bridges between cells and their matrix. Curr Biol 2002;12:R279-81.
20. Wang X, LeMaire SA, Chen L, Carter SA, Shen YH, Gan Y et al. Decreased expression of fibulin-5 correlates with reduced elastin in thoracic aortic dissection. Surgery 2005;138:352-9.
21. Baxter BT. Heritable diseases of the blood vessels. Cardiovasc Pathol 2005;14:185-8.
22. Gleason TG. Heritable disorders predisposing to aortic dissection. Semin Thorac Cardiovasc Surg 2005;17:274-81.
23. Wilson SK, Hutchins GM. Aortic dissecting aneurysms: causative factors in 204 subjects. Arch Pathol Lab Med 1982;106:175-80.
24. Svensson LG, Labib SB, Eisenhauer AC, Butterly JR. Intimai tear without hematoma : an important variant of aortic dissection that can elude current imaging techniques. Circulation 1999;99:1331-6.
25. Moon MR. Approach to the treatment of aortic dissection. Surg Clin North Am 2009;89:869-93, ix.
26. Tam ASM, Sapp MC, Roach MR. The effect of tear depth on the propagation of aortic dissections in isolated porcine thoracic aorta. J Biomech 1998;31:673-6.
27. Li DY, Brooke B, Davis EC, Mecham RP, Sorensen LK, Boak BB et al. Elastin is an essential determinant of arterial morphogenesis. Nature 1998;393:276-80.
28. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan Syndrome. Circ Res 2001;88:37-43.
29. Dietz HC, Pyeritz RE, Hall BD, Cadle RG, Hamosh A, Schwartz J et al. The Marfan syndrome locus: confirmation of assignment to chromosome 15 and identification of tightly linked markers at 15q15-q21.3. Genomics 1991;9:355-61.
30. Dietz HC, Cutting GR, Pyeritz RE, Maslen CL, Sakai LY, Corson GM et al. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991;352:337-9.
31. Nijbroek G, Sood S, Mcintosh I, Francomano CA, Bull E, Pereira L et al. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995;57:8-21.
32. Montgomery RA, Geraghty MT, Bull E, Gelb BD, Johnson M, Mcintosh I et al. Multiple molecular mechanisms underlying subdiagnostic variants of Marfan syndrome. Am J Hum Genet 1998;63:1703-11.
33. Arteaga-Solis E, Gayraud B, Ramirez F. Elastic and collagenous networks in vascular diseases. Cell Struct Funct 2000;25:69-72.
34. Pereira L, Lee SY, Gayraud B, Andrikopoulos K, Shapiro SD, Bunton T et al. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 1999;96:3819-23.
35. Neptune ER, Frischmeyer PA, Arking DE, Myers L, Bunton TE, Gayraud B et al. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003;33:407-11.
36. Gibson MA, Hatzinikolas G, Davis EC, Baker E, Sutherland GR, Mecham RP. Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol 1995;15:6932-42.
37. Lack J, O'Leary JM, Knott V, Yuan X, Rifkin DB, Handford PA et al. Solution structure of the third TB domain from LTBP1 provides insight into assembly of the large latent complex that sequesters latent TGF-beta. J Mol Biol 2003;334:281-91.
38. Sinha S, Heagerty AM, Shuttleworth CA, Kielty CM. Expression of latent TGF-beta binding proteins and association with TGF-beta 1 and fibrillin-1 following arterial injury. Cardiovasc Res 2002;53:971-83.
39. Dietz HC. TGF-beta in the pathogenesis and prevention of disease: a matter of aneurysmic proportions. J Clin Invest 2010;120:403-7.
40. Loeys BL, Chen J, Neptune ER, Judge DP, Podowski M, Holm T et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005;37:275-81.
41. Loeys BL, Schwarze U, Holm T, Callewaert BL, Thomas GH, Pannu H et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006;355:788-98.
42. Hanada K, Vermeij M, Garinis GA, de Waard MC, Kunen MG, Myers L et al. Perturbations of vascular homeostasis and aortic valve abnormalities in fibulin-4 deficient mice. Circ Res 2007;100:738-46.
43. Gomez D, Al Haj Zen A, Borges LF, Philippe M, Gutierrez PS, Jondeau G et al. Syndromic and non-syndromic aneurysms of the human ascending aorta share activation of the Smad2 pathways J Pathol 2009;218:131-42.
44. Kothapalli CR, Ramamurthi A. Induced elastin regeneration by chronically activated smooth muscle cells for targeted aneurysm repair. Acta Biomaterialia 2010;6:170-8.
45. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of marfan syndrome. Science 2006;312:117-21.
46. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC III. Angiotensin II blockade and aortic-root dilation in Marfan's Syndrome. N Engl J Med 2008;358:2787-95.
47. Lacro RV, Dietz HC, Wruck LM, Bradley TJ, Colan SD, Devereux RB et al. Rationale and design of a randomized clinical trial of [beta]-blocker therapy (atenolol) versus angiotensin II receptor blocker therapy (losartan) in individuals with Marfan syndrome. American Heart Journal 2007;154:624-31.
48. Cohen JR, Keegan L, Sarfati I, Danna D, Ilardi C, Wise L. Neutrophil Chemotaxis and neutrophil elastase in the aortic wall in patients with abdominal aortic aneurysms. J Invest Surg 1991;4:423-30.
49. Nackman GB, Karkowski FJ, Halpern VJ, Gaetz HP, Tilson MD. Elastin degradation products induce adventitial angiogenesis in the Anidjar/Dobrin rat aneurysm model. Surgery 1997;122:39-44.
50. Petersen E, Wagberg F, Angquist KA. Serum concentrations of elastin-derived peptides in patients with specific manifestations of atherosclerotic disease. Eur J Vase Endovasc Surg 2002;24:440-4.
51. Shinohara T, Suzuki K, Okada M, Shiigai M, Shimizu M, Maehara T et al. Soluble elastin fragments in serum are elevated in acute aortic dissection. Arterioscler Thromb Vasc Biol 2003;23:1839-44.
52. Senior RM, Griffin GL, Mecham RP, Wrenn DS, Prasad KU, Urry DW. Val-Gly-Val-Ala-Pro-Gly, a repeating peptide in elastin, is chemotactic for fibroblasts and monocytes. J Cell Biol 1984;99:870-4.
53. Senior RM, Griffin GL, Mecham RP. Chemotactic activity of elastin-derived peptides. J Clin Invest 1980;66:859-62.
54. Senior RM, Griffin GL, Mecham RP. Chemotactic responses of fibroblasts to tropoelastin and elastin-derived peptides. J Clin Invest 1982;70:614-8.
55. Huet E, Brassart B, Cauchard JH, Debelle L, Birembaut P, Wallach J et al. Cumulative influence of elastin peptides and plasminogen on matrix metalloproteinase activation and type I collagen invasion by HT-1080 fibrosarcoma cells. Clin Exp Metastasis 2002;19:107-17.
56. Brassart B, Fuchs P, Huet E, Alix AJ, Wallach J, Tamburro AM et al. Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem 2001;276:5222-7.
57. Simionescu A, Philips K, Vyavahare N. Elastin-derived peptides and TGF-[beta]1 induce osteogenic responses in smooth muscle cells. Biochem Biophys Res Commun 2005;334:524-32.
58. Duca L, Floquet N, Alix AJP, Haye B, Debelle L. Elastin as a matrikine. Crit Rev Oncol Hematol 2004;49:235-44.
59. Hinek A. Biological roles of the non-integrin elastin/laminin receptor. Biol Chem 1996;377:471-80.
60. Duca L, Debelle L, Debret R, Antonicelli F, Hornebeck W, Haye B. The elastin peptides-mediated induction of pro-collagenase-1 production by human fibroblasts involves activation of MEK/ERK pathway via PKA- and PI(3)K-dependent signaling. FEBS Letters 2002;524:193-8.
61. Grosso LE, Scott M. Peptide sequences selected by BA4, a tropoelastin-specific monoclonal antibody, are ligands for the 67-kilodalton bovine elastin receptor. Biochemistry 1993;32:13369-74.
62. Guo G, Booms P, Halushka M, Dietz HC, Ney A, Strieker S et al. Induction of macrophage Chemotaxis by aortic extracts of the mgR marfan mouse model and a GxxPG-containing fibrillin-1 fragment. Circulation 2006;114:1855-62.
63. Booms P, Ney A, Barthel F, Moroy G, Counsell D, Gille C et al. A fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis. J Mol Cell Cardiol 2006;40:234-46.
64. Miller D, Stinson E, Oyer P, Rossiter S, Reitz B, Griepp R et al. Operative treatment of aortic dissections. Experience with 125 patients over a sixteen-year period. J Thorac Cardiovasc Surg 1979;78:365-82.
65. Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg 1970;10:237-47.
66. Schneiderman J, Bordin GM, Adar R, Smolinsky A, Seiffert D, Engelberg I et al. Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms. Am J Pathol 1998;152:703-10.
67. Nienaber CA, Eagle KA. Aortic dissection: new frontiers in diagnosis and management: Part I: from etiology to diagnostic strategies. Circulation 2003;108:628-35.
68. Kodama K, Nishigami K, Sakamoto T, Sawamura T, Hirayama T, Misumi H et al. Tight heart rate control reduces secondary adverse events in patients with type B acute aortic dissection. Circulation 2008;118:S167-70.
69. Elefteriades JA, Lovoulos CJ, Coady MA, Tellides G, Kopf GS, Rizzo JA. Management of descending aortic dissection. Ann Thorac Surg 1999;67:2002-5.
70. Bernard Y, Zimmermann H, Chocron S, Litzler J-F, Kastler B, Etievent J-P et al. False lumen patency as a predictor of late outcome in aortic dissection. Am J Cardiol 2001;87:1378-82.
71. Mastracci TM, Greenberg RK. Follow-up paradigms for stable aortic dissection. Semin Vase Surg 2009;22:69-73.
72. Svensson LG, Kouchoukos NT, Miller DC, Bavaria JE, Coselli JS, Curi MA et al. Expert consensus document on the treatment of descending thoracic aortic disease using endovascular stentgrafts. Ann Thorac Surg 2008;85:S1-S4l.
73. Kuehl H, Eggebrecht H, Boes T, Antoch G, Rosenbaum S, Ladd S et al. Detection of inflammation in patients with acute aortic syndrome: comparison of FDG-PET/CT imaging and serological markers of inflammation. Heart 2008;94:1472-7.
74. Koullias GJ, Ravichandran P, Korkolis DP, Rimm DL, Elefteriades JA. Increased tissue microarray matrix metaltoproteinase expression favors proteolysis in thoracic aortic aneurysms and dissections. Ann Thorac Surg 2004;78:2106-10.
75. Akiyama M, Ohtani H, Sato E, Nagura H, Tabayashi K. Upregulation of matrix metalloproteinase-2 and membrane-type 1-matrix metalloproteinase were coupled with that of type I procollagen in granulation tissue response after the onset of aortic dissection. Virchows Archiv 2006;448:811-21.
76. Baxter BT, Pearce WH, Waltke EA, Littooy FN, Hallett JW Jr, Kent KC et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vase Surg 2002;36:1-12.
77. Curci JA, Mao D, Bohner DG, Allen BT, Rubin BG, Reilly JM et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vase Surg 2000;31:325-42.
78. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vase Surg 2001;34:606-10.
79. Chung AWY, Yang HHC, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 2008;102:e73-85.